Saba W[au] - Search Results

Year	Number of Results
1965	2
1967	1
1970	1
1997	1
2001	1
2005	3
2006	4
2007	3
2008	2
2009	1
2010	3
2011	3
2012	4
2013	3
2015	2
2016	4
2017	5
2018	1
2019	1
2020	2
2021	4
2022	4
2023	1

1

Contribution of TSPO imaging in the understanding of the state of gliosis in substance use disorders.

Leroy C, Saba W. Leroy C, et al. Among authors: saba w. Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):186-200. doi: 10.1007/s00259-021-05408-x. Epub 2021 May 27. Eur J Nucl Med Mol Imaging. 2021. PMID: 34041563 Review.

2

Radiolabeling and brain penetration of [¹¹ C]VU0071063, a ligand of type 1 sulfonylurea receptors for positron emission tomography imaging.

Caillé F, Saba W, Goutal S, Breuil L, Kuhnast B, Tournier N. Caillé F, et al. Among authors: saba w. J Labelled Comp Radiopharm. 2022 Feb;65(2):28-35. doi: 10.1002/jlcr.3957. Epub 2021 Nov 30. J Labelled Comp Radiopharm. 2022. PMID: 34796549

3

Comparative vulnerability of PET radioligands to partial inhibition of P-glycoprotein at the blood-brain barrier: A criterion of choice?

Breuil L, Marie S, Goutal S, Auvity S, Truillet C, Saba W, Langer O, Caillé F, Tournier N. Breuil L, et al. Among authors: saba w. J Cereb Blood Flow Metab. 2022 Jan;42(1):175-185. doi: 10.1177/0271678X211045444. Epub 2021 Sep 9. J Cereb Blood Flow Metab. 2022. PMID: 34496661 Free PMC article.

4

Pharmacokinetic Imaging Using ^99mTc-Mebrofenin to Untangle the Pattern of Hepatocyte Transporter Disruptions Induced by Endotoxemia in Rats.

Marie S, Hernández-Lozano I, Le Vée M, Breuil L, Saba W, Goislard M, Goutal S, Truillet C, Langer O, Fardel O, Tournier N. Marie S, et al. Among authors: saba w. Pharmaceuticals (Basel). 2022 Mar 24;15(4):392. doi: 10.3390/ph15040392. Pharmaceuticals (Basel). 2022. PMID: 35455390 Free PMC article.

5

Comparison of the Blood-Brain Barrier Transport and Vulnerability to P-Glycoprotein-Mediated Drug-Drug Interaction of Domperidone versus Metoclopramide Assessed Using In Vitro Assay and PET Imaging.

Breuil L, Goutal S, Marie S, Del Vecchio A, Audisio D, Soyer A, Goislard M, Saba W, Tournier N, Caillé F. Breuil L, et al. Among authors: saba w. Pharmaceutics. 2022 Aug 9;14(8):1658. doi: 10.3390/pharmaceutics14081658. Pharmaceutics. 2022. PMID: 36015284 Free PMC article.

6

Nalmefene alleviates the neuroimmune response to repeated binge-like ethanol exposure: A TSPO PET imaging study in adolescent rats.

Tournier N, Pottier G, Caillé F, Coulon C, Goislard M, Jégo B, Negroni J, Leroy C, Saba W. Tournier N, et al. Among authors: saba w. Addict Biol. 2021 May;26(3):e12962. doi: 10.1111/adb.12962. Epub 2020 Sep 7. Addict Biol. 2021. PMID: 32896074

7

Metabolism and quantification of [(18)F]DPA-714, a new TSPO positron emission tomography radioligand.

Peyronneau MA, Saba W, Goutal S, Damont A, Dollé F, Kassiou M, Bottlaender M, Valette H. Peyronneau MA, et al. Among authors: saba w. Drug Metab Dispos. 2013 Jan;41(1):122-31. doi: 10.1124/dmd.112.046342. Epub 2012 Oct 12. Drug Metab Dispos. 2013. PMID: 23065531

8

Corrigendum to "Evaluation of TSPO PET imaging, a marker of glial activation, to study the neuroimmune footprints of morphine exposure and withdrawal" [Drug Alcohol Depend. 170 (2017) 43-50].

Auvity S, Goutal S, Thézé B, Chaves C, Hosten B, Kuhnast B, Saba W, Boisgard R, Buvat I, Cisternino S, Tournier N. Auvity S, et al. Among authors: saba w. Drug Alcohol Depend. 2019 Aug 1;201:266-268. doi: 10.1016/j.drugalcdep.2019.05.002. Epub 2019 Jun 5. Drug Alcohol Depend. 2019. PMID: 31176599 No abstract available.

9

Validation of a pharmacological imaging challenge using ¹¹C-buprenorphine and ¹⁸F-2-fluoro-2-deoxy-D-glucose positron emission tomography to study the effects of buprenorphine to the rat brain.

Soyer A, Leterrier S, Breuil L, Goislard M, Leroy C, Saba W, Thibault K, Bo GD, Bottlaender M, Caillé F, Goutal S, Tournier N. Soyer A, et al. Among authors: saba w. Front Neurosci. 2023 May 10;17:1181786. doi: 10.3389/fnins.2023.1181786. eCollection 2023. Front Neurosci. 2023. PMID: 37234261 Free PMC article.

10

Acute Morphine Exposure Increases the Brain Distribution of [18F]DPA-714, a PET Biomarker of Glial Activation in Nonhuman Primates.

Auvity S, Saba W, Goutal S, Leroy C, Buvat I, Cayla J, Caillé F, Bottlaender M, Cisternino S, Tournier N. Auvity S, et al. Among authors: saba w. Int J Neuropsychopharmacol. 2017 Jan 1;20(1):67-71. doi: 10.1093/ijnp/pyw077. Int J Neuropsychopharmacol. 2017. PMID: 27581167 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

43 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year